You are here

dacomitinib

Pfizer nabs fast OK for a new frontline lung cancer drug as pharma giant shows off its new R&D strategy

Endpoints

Fri, 09/28/18 - 10:27 am

non-small cell lung cancer

Attention Biotech Investors: Mark Your Calendar For These September PDUFA Dates

Yahoo/Benzinga

Sat, 09/1/18 - 03:38 pm

Teva Pharmaceutical

Adamis Pharmaceuticals

Riding a wave of positive PhIII readouts, Pfizer gets a snap review for lung cancer drug dacomitinib

Endpoints

Wed, 04/4/18 - 10:51 am

priority review

Can Pfizer Inc. Recover From Its Latest Lung Cancer Setback?

Motley Fool

Thu, 01/30/14 - 10:11 am

non-small cell lung cancer

Pfizer cancer drug fails in 2 late-stage studies, results from 3rd trial expected in 2015

Yahoo/AP

Mon, 01/27/14 - 08:54 am

non-small cell lung cancer

The SFJ Pharmaceuticals Group Announces Agreement With Pfizer to Co-develop Dacomitinib as First-Line Treatment for Patients With Advanced Non-small Cell Lung Cancer

Sacramento Bee, CA

Sat, 09/8/12 - 11:28 am

non-small cell lung cancer

SJF Pharmaceuticals